ArticlebioRxiv : the preprint server for biology2026
HERMES: Holographic Equivariant neuRal network model for Mutational Effect and Stability prediction.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Accurately predicting how amino acid substitutions alter protein function is a central challenge in biology, with applications from interpreting disease variants to engineering vaccines and therapeutic proteins. We introduce HERMES, a family of fast, structure-based models that predict mutational effects from the local three-dimensional atomic environment around each residue. Pre-trained on the masked amino-acid prediction task, HERMES shows strong zero-shot performance for predicting changes in thermodynamic stability and protein-protein binding affinity. We find that this pre-training induces a bias toward substitutions with similar size to the wild-type. To address this, we develop an amortized fine-tuning strategy that incorporates packing flexibility, substantially reducing size-based bias while preserving sensitivity to mutational effects. We demonstrate that HERMES can then be fine-tuned on experimental measurements without adding parameters or relying on costly data augmentation, achieving performance competitive with state-of-the-art stability predictors. Finally, we show that HERMES identifies antigen-stabilizing mutations across multiple viral envelope proteins, enabling computationally efficient, structure-guided vaccine design. Together, these results establish HERMES as a practical and accurate framework for structure-based mutational effect prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.